These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9780261)

  • 21. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA; Stensson A; Schön K; Lycke N
    Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice.
    Eaton KA; Mefford ME
    Infect Immun; 2001 Feb; 69(2):1025-31. PubMed ID: 11159999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
    Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
    Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation, immunity, and vaccines for Helicobacter infection.
    Permin H; Andersen LP
    Helicobacter; 2005; 10 Suppl 1():21-5. PubMed ID: 16178967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manifestations of the local gastric immune response in gnotobiotic piglets infected with Helicobacter pylori.
    Krakowka S; Ringler SS; Eaton KA; Green WB; Leunk R
    Vet Immunol Immunopathol; 1996 Jul; 52(3):159-73. PubMed ID: 8809998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori infection, immune response and vaccination.
    Lembo A; Caradonna L; Magrone T; Mastronardi ML; Caccavo D; Jirillo E; Amati L
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):199-208. PubMed ID: 12477286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant.
    Chionh YT; Arulmuruganar A; Venditti E; Ng GZ; Han JX; Entwisle C; Ang CS; Colaco CA; McNulty S; Sutton P
    Vaccine; 2014 Apr; 32(20):2350-8. PubMed ID: 24625340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study.
    Sutton P; Danon SJ; Walker M; Thompson LJ; Wilson J; Kosaka T; Lee A
    Gut; 2001 Oct; 49(4):467-73. PubMed ID: 11559641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization.
    Czinn SJ; Cai A; Nedrud JG
    Vaccine; 1993; 11(6):637-42. PubMed ID: 8322486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives of anti-H. pylori vaccination.
    Saldinger PF; Blum AL; Corthésy-Theulaz IE
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():59-65. PubMed ID: 9440056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
    Kubota E; Joh T; Tanida S; Sasaki M; Kataoka H; Watanabe K; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Yamada T; Mori Y; Fujita F; Shimura T; Ohara H; Isaka M; Yasuda Y; Itoh M
    Helicobacter; 2005 Aug; 10(4):345-52. PubMed ID: 16104951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models and vaccine development.
    Lee A
    Baillieres Clin Gastroenterol; 1995 Sep; 9(3):615-32. PubMed ID: 8563056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori immunology and vaccines.
    Vorobjova T; Watanabe T; Chiba T
    Helicobacter; 2008 Oct; 13 Suppl 1():18-22. PubMed ID: 18783517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W; Wu W; Xu X
    Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of Helicobacter pylori in conventionalized piglets.
    Eaton KA; Morgan DR; Krakowka S
    J Infect Dis; 1990 Jun; 161(6):1299-301. PubMed ID: 2345307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
    Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in vaccination against Helicobacter pylori.
    Sutton P
    Vaccine; 2001 Mar; 19(17-19):2286-90. PubMed ID: 11257349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autogenous vaccination against Helicobacter pylori.
    Kaplan L
    S Afr Med J; 1993 Dec; 83(12):922-3. PubMed ID: 8115933
    [No Abstract]   [Full Text] [Related]  

  • 40. An epizootic of lymphoplasmacytic gastritis attributed to Helicobacter pylori infection in cynomolgus monkeys (Macaca fascicularis).
    Reindel JF; Fitzgerald AL; Breider MA; Gough AW; Yan C; Mysore JV; Dubois A
    Vet Pathol; 1999 Jan; 36(1):1-13. PubMed ID: 9921750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.